Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2016201720202021
Revenues<1m<1m<1m<1m
% growth-100 %-161 %
EBITDA(1.7m)(1.7m)(2.5m)(2.5m)
% EBITDA margin(558 %)(280 %)(722 %)(279 %)
Profit(1.7m)(1.7m)(2.4m)(2.5m)
% profit margin(552 %)(280 %)(679 %)(275 %)

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Spinout
N/A

€1.0m

Early VC

N/A

-

N/A

Acquisition
Total Funding$1.1m

Recent News about OxyMem

Edit
More about OxyMem
Edit

OxyMem solves energy intensive wastewater treatment with an innovative ‘Drop in’ solution for wastewater aeration, the Membrane Aerated Biofilm Reactor (MABR). OxyMem MABR complements existing treatment systems and delivers up to 50% additional biological capacity (Incrementally) in an existing aeration or alternatively enables you to replace a legacy system.

Conventional wastewater treatment consumes 2-3% of a nation’s electricity production. This is due a 100 years reliance on bubble diffusion for conventional treatment plants which will typically suffer energy losses of 65-70% in the process because of the oxygen transfer limitations in the process. OxyMem does not have any such limitations.

OxyMem uses hollow fibre gas permeable membranes to support a fixed film ecosystem for the biology which allows for direct delivery of oxygen to the micro-organisms. OxyMem can achieve 95% oxygen transfer rates which results in superior energy performance (75% saving), lower sludge production (50% less sludge), along with impressive process resilience.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.